Carson Wealth (CWM LLC)’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-544
| Closed | -$51K | – | 4026 |
|
|
2021
Q4 | $51K | Buy |
+544
| New | +$35.8K | ﹤0.01% | 1561 |
|
|
2021
Q2 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2021
Q1 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q4 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q3 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q2 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2020
Q1 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q4 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q3 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q2 | $26K | Hold |
388
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q1 | $26K | Buy |
+388
| New | +$17.8K | ﹤0.01% | 1680 |
|
|
2018
Q2 | – | Sell |
-150
| Closed | -$6K | – | 1804 |
|
|
2018
Q1 | $6K | Buy |
+150
| New | +$5.83K | ﹤0.01% | 988 |
|
|
2017
Q4 | – | Sell |
-10
| Closed | – | – | 1611 |
|
|
2017
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1586 |
|
|
2017
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 1340 |
|
|
2017
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 1357 |
|
|
2016
Q4 | $0 | Buy |
+10
| New | +$155 | ﹤0.01% | 1212 |
|
Carson Wealth (CWM LLC)'s ARNA Position: Q1 2022 in Review
Carson Wealth (CWM LLC) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 544 shares — an estimated $51K sold.
Carson Wealth (CWM LLC) first reported a position in ARNA in Q4 2016 and held it in 16 quarters. The position peaked at $51K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Carson Wealth (CWM LLC) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 544 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $51K.
- Carson Wealth (CWM LLC) first reported a position in Arena Pharmaceuticals Inc in Q4 2016 and held it in 16 quarters.
- Carson Wealth (CWM LLC)'s Arena Pharmaceuticals Inc position peaked at $51K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2022, filed 21 Apr 2022.